Refine
Year of publication
Document Type
- Article (44)
- Preprint (5)
- Doctoral Thesis (1)
- Review (1)
Language
- English (46)
- German (3)
- Portuguese (2)
Has Fulltext
- yes (51)
Is part of the Bibliography
- no (51)
Keywords
- cancer (2)
- 3T3-L1 mouse fibroblasts (1)
- 5-lipoxygenase (1)
- ACL (1)
- AGMO (1)
- Actin (1)
- Alleles (1)
- Aortic valve (1)
- Bipolar disorder (1)
- Blood pressure (1)
Institute
Bone vasculature provides protection and signals necessary to control stem cell quiescence and renewal1. Specifically, type H capillaries, which highly express Endomucin, constitute the endothelial niche supporting a microenvironment of osteoprogenitors and long-term hematopoietic stem cells2–4. The age-dependent decline in type H endothelial cells was shown to be associated with bone dysregulation and accumulation of hematopoietic stem cells, which display cell-intrinsic alterations and reduced functionality3. The regulation of bone vasculature by chronic diseases, such as heart failure is unknown. Here, we describe the effects of myocardial infarction and post-infarction heart failure on the vascular bone cell composition. We demonstrate an age-independent loss of type H bone endothelium in heart failure after myocardial infarction in both mice and in humans. Using single-cell RNA sequencing, we delineate the transcriptional heterogeneity of human bone marrow endothelium showing increased expression of inflammatory genes, including IL1B and MYC, in ischemic heart failure. Inhibition of NLRP3-dependent IL-1β production partially prevents the post-myocardial infarction loss of type H vasculature in mice. These results provide a rationale for using anti-inflammatory therapies to prevent or reverse the deterioration of vascular bone function in ischemic heart disease.